We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP32604
Poster Title: Clinical and Scientific Evidence for the Safety and Efficacy of XanMax® Lutein/Zeaxanthin
Submitted on 21 May 2020
Author(s): Priya, M.K., Lelah, M.
Affiliations: Katra (Phytochem) India, Pvt. Ltd., Bangalore, India and NutriScience Innovations LLC, Trumbull CT, USA
This poster was presented at TBD
Poster Views: 1,648
Submitted on 21 May 2020
Author(s): Priya, M.K., Lelah, M.
Affiliations: Katra (Phytochem) India, Pvt. Ltd., Bangalore, India and NutriScience Innovations LLC, Trumbull CT, USA
This poster was presented at TBD
Poster Views: 1,648
Abstract: We review the direct evidence for the safety and efficacy of XanMax® 2002 free lutein/zeaxanthin. Animal studies demonstrated that XanMax® 2002 lutein/zeaxanthin was well absorbed into the blood and with increased macular deposits of lutein and zeaxanthin, and increased antioxidant potential. In a human study, these increases in macular levels of lutein and zeaxanthin were demonstrated to improve macular pigment optical density (MPOD) by 40%. The three studies, when integrated together, demonstrate that supplementing the diet with XanMax® 2002 can be measured by absorption into the blood, deposition in the macular, and improvements in MPOD. No abnormalities or adverse events were reported. We conclude that supplementation with XanMax® 2002 lutein/zeaxanthin is a safe and effective means to increase macular pigmentation, therefore demonstrating benefits for healthy aging and improved eye health.
Summary: We review the direct evidence for the safety and efficacy of XanMax® 2002 free lutein/zeaxanthin.We conclude that supplementation with XanMax® 2002 lutein/zeaxanthin is a safe and effective means to increase macular pigmentation, therefore demonstrating benefits for healthy aging and improved eye health.References: 1. Gao, Shashaet al. “Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells.” Molecular Visionvol. 17 (2011): 3180-90
2. WidomskaJ, ZarebaM, SubczynskiWK. Can Xanthophyll-Membrane Interactions Explain Their Selective Presence in the Retina and Brain? Foods 2016;5(1)
3. https://www.nature.com/articles/eye201398
4. https://www.ncbi.nlm.nih.gov/pubmed/7933422
5. Age Related Eye Disease Study 2 (AREDS2) Research Group (2014). JAMA Ophthalmol . 132: 142 149
6. Pharmacognosy Magazine, Volume 14, Issue 54, April-June 2018, pp. 268-274
7. Study Protocol CTRI2016/10/007413 http://ctri.nic.in/Clinicaltrials/login.php
Summary: We review the direct evidence for the safety and efficacy of XanMax® 2002 free lutein/zeaxanthin.We conclude that supplementation with XanMax® 2002 lutein/zeaxanthin is a safe and effective means to increase macular pigmentation, therefore demonstrating benefits for healthy aging and improved eye health.References: 1. Gao, Shashaet al. “Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells.” Molecular Visionvol. 17 (2011): 3180-90
2. WidomskaJ, ZarebaM, SubczynskiWK. Can Xanthophyll-Membrane Interactions Explain Their Selective Presence in the Retina and Brain? Foods 2016;5(1)
3. https://www.nature.com/articles/eye201398
4. https://www.ncbi.nlm.nih.gov/pubmed/7933422
5. Age Related Eye Disease Study 2 (AREDS2) Research Group (2014). JAMA Ophthalmol . 132: 142 149
6. Pharmacognosy Magazine, Volume 14, Issue 54, April-June 2018, pp. 268-274
7. Study Protocol CTRI2016/10/007413 http://ctri.nic.in/Clinicaltrials/login.php
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Composition Analysis Case Study
Tylor
Application of HPLC Technology in Drug Detection
Alex Brown
Science lab Report on H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
AN OVERVIEW OF NANOTECHNOLOGY IN PHARMACY
Utpal Bhui
